UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension

The New England journal of medicine, 2013-07, Vol.369 (4), p.319-329

2013

Volltextzugriff (PDF)

Chronic Thromboembolic Pulmonary Hypertension

Journal of the American College of Cardiology, 2013-12, Vol.62 (25), p.D92-D99

2013

Volltextzugriff (PDF)

Macitentan in Pulmonary Arterial Hypertension: A Focus on Combination Therapy in the SERAPHIN Trial

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2018-02, Vol.18 (1), p.1-11

2018

Volltextzugriff (PDF)

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2)

The European respiratory journal, 2015-05, Vol.45 (5), p.1293-1302

2015

Volltextzugriff (PDF)

Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension

Journal of the American College of Cardiology, 2008-12, Vol.52 (25), p.2127-2134

2008

Volltextzugriff (PDF)

RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors

The European respiratory journal, 2017-09, Vol.50 (3), p.1602425-1602425

2017

Volltextzugriff (PDF)

Chronic thromboembolic pulmonary hypertension: role of medical therapy

The European respiratory journal, 2013-04, Vol.41 (4), p.985-990

2013

Volltextzugriff (PDF)

Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1)

Chest, 2014-11, Vol.146 (5), p.1274-1285

2014

Volltextzugriff (PDF)

The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension

PloS one, 2021-01, Vol.16 (1), p.e0245752-e0245752

2021

Volltextzugriff (PDF)

Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality

Journal of the American College of Cardiology, 2018-02, Vol.71 (7), p.752-763

2018

Volltextzugriff (PDF)

Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial

The lancet respiratory medicine, 2016-05, Vol.4 (5), p.372-380

2016

Volltextzugriff (PDF)

Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial

The lancet respiratory medicine, 2016-05, Vol.4 (5), p.361-371

2016

Volltextzugriff (PDF)

Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial

BMC cardiovascular disorders, 2017-09, Vol.17 (1), p.239-239, Article 239

2017

Volltextzugriff (PDF)

Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial

PloS one, 2018-03, Vol.13 (3), p.e0193226-e0193226

2018

Volltextzugriff (PDF)

The left atrial substrate plays a significant role in the development of complex atrial tachycardia in patients with precapillary pulmonary hypertension

BMC cardiovascular disorders, 2019-06, Vol.19 (1), p.157-157, Article 157

2019

Volltextzugriff (PDF)

Prediction Score for persisting perfusion defects after pulmonary embolism

Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, 2020-12, Vol.164 (4), p.394-400

2020

Volltextzugriff (PDF)

Computed tomography angiographic parameters of pulmonary artery as prognostic factors of residual pulmonary hypertension after pulmonary endarterectomy

Journal of international medical research, 2021-03, Vol.49 (3), p.3000605211002024-3000605211002024

2021

Volltextzugriff (PDF)

The impact of riociguat on clinical parameters and quality of life in patients with chronic thromboembolic pulmonary hypertension - results of a retrospective clinical registry

Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, 2021-06, Vol.165 (2), p.157-161

2021

Volltextzugriff (PDF)

Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension

Chest, 2017-01, Vol.151 (1), p.106-118

2017

Volltextzugriff (PDF)

PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic

Orphanet journal of rare diseases, 2021-05, Vol.16 (1), p.196-196, Article 196

2021

Volltextzugriff (PDF)

Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications

Medicina (Kaunas, Lithuania), 2022-10, Vol.58 (11), p.1538

2022

Volltextzugriff (PDF)

Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension

Heart (British Cardiac Society), 2017-04, Vol.103 (8), p.599-606

2017

Volltextzugriff (PDF)

The incidence of the thrombophilic SNPs rs6025, rs1799963, rs2066865, rs2289252, and rs8176719 in chronic thromboembolic pulmonary hypertension

Clinical and applied thrombosis/hemostasis, 2024-01, Vol.30, p.10760296241271369

2024

Volltextzugriff (PDF)

Pulmonary perfusion in long‐term survivors of COVID‐19‐related severe acute respiratory distress syndrome treated by extracorporeal membrane oxygenation

Pulmonary circulation, 2024-07, Vol.14 (3), p.e12431-n/a

2024

Volltextzugriff (PDF)

Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients

International journal of cardiology, 2014-03, Vol.172 (2), p.332-339

2014

Volltextzugriff (PDF)

1 – 25 von 143

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(127)

Publikationsform

Artikel
(137)
Tagungsberichte
(6)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(87)
Life Sciences & Biomedicine
(81)
Humans
(54)
Female
(41)
Cardiovascular System & Cardiology
(40)
Male
(40)
Cardiac & Cardiovascular Systems
(38)
Middle Aged
(37)
Pulmonary Hypertension
(31)
Aged
(29)
Treatment Outcome
(27)
Adult
(25)
Hypertension, Pulmonary - Drug Therapy
(23)
Respiratory System
(21)
Pulmonary Arterial Hypertension
(18)
Chronic Disease
(17)
Chronic Thromboembolic Pulmonary Hypertension
(17)
Hypertension, Pulmonary - Physiopathology
(16)
Double-Blind Method
(15)
General & Internal Medicine
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension

Chronic Thromboembolic Pulmonary Hypertension

Macitentan in Pulmonary Arterial Hypertension: A Focus on Combination Therapy in the SERAPHIN Trial

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2)

Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension

RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors

Chronic thromboembolic pulmonary hypertension: role of medical therapy

Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1)

The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension

Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality

Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial

Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial

Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial

Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial

The left atrial substrate plays a significant role in the development of complex atrial tachycardia in patients with precapillary pulmonary hypertension

Prediction Score for persisting perfusion defects after pulmonary embolism

Computed tomography angiographic parameters of pulmonary artery as prognostic factors of residual pulmonary hypertension after pulmonary endarterectomy

The impact of riociguat on clinical parameters and quality of life in patients with chronic thromboembolic pulmonary hypertension - results of a retrospective clinical registry

Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension

PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic

Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications

Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension

The incidence of the thrombophilic SNPs rs6025, rs1799963, rs2066865, rs2289252, and rs8176719 in chronic thromboembolic pulmonary hypertension

Pulmonary perfusion in long‐term survivors of COVID‐19‐related severe acute respiratory distress syndrome treated by extracorporeal membrane oxygenation

Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients

Suchergebnisse filtern